View graph of relations


      Nanomedicine, Antibodies, Antibody-Drug Conjugates (ADCs), cathepsin proteases, cancer, inflammation, infection

      Research Statement

      Professor Chris Scott is Chair of Pharmaceutical Biosciences and at the School of Pharmacy, Queen’s University Belfast and Centre for Cancer Research and Cell Biology.  Following a primary degree in Biochemistry he undertook a PhD and post doctoral training at Queen’s in molecular enzymology.  In 2001, Chris was one of the founding members of QUB spinout company Fusion Antibodies Ltd., before returning to Queen’s in 2003 to take up an academic position.  Chris is internationally renowned for his work in development of antibody and nanomedicine-based therapies for the treatment of cancer and other conditions.  Work in his laboratory is funded by agencies such as Medical Research Council, HSCNI, and various industrial sources such as AstraZeneca.  He also held a Royal Society Industrial Fellowship with GSK from 2012-15, and won the Vice Chancellor’s Prize for Innovation in 2015 with his group’s work on developing a novel nanomedicine for the treatment of sepsis and other inflammatory conditions. 

      View all

      Frequent Journals

      • Journal of biological chemistry

        ISSNs: 0021-9258

        Additional searchable ISSN (Electronic): 1083-351X

        American Society for Biochemistry and Molecular Biology Inc.

        Scopus rating (2016): CiteScore 4.17 SJR 2.755 SNIP 1.125


      • Biochimie

        ISSNs: 0300-9084


        Scopus rating (2016): CiteScore 3.2 SJR 1.425 SNIP 0.975


      • Biochemical Journal

        ISSNs: 0264-6021

        Additional searchable ISSN (Electronic): 1470-8728

        Portland Press Ltd.

        Scopus rating (2016): CiteScore 3.63 SJR 2.341 SNIP 0.99


      • Biochemical and Biophysical Research Communications

        ISSNs: 0006-291X

        Additional searchable ISSN (Electronic): 1090-2104

        Academic Press Inc.

        Scopus rating (2016): CiteScore 2.51 SJR 1.091 SNIP 0.688


      • Oncotarget

        ISSNs: 1949-2553

        Impact Journals

        Scopus rating (2016): CiteScore 4.73 SJR 1.927 SNIP 1.056


      View all »

      Contribution to conference papers, events and activities

      ID: 31240